MPO, NE, cfDNA, citH3 and other NET-related biomarkers should be investigated in RCTs for their diagnostic and prognostic accuracy in sepsis and sepsis-related thrombotic events and other complications to define their cut-offs and diagnostic and prognostic value. The gene discussed is MPO; the disease is Sepsis.